Ilio-Funkton (Simeticone)

Simeticone acts as a surfactant that lowers the surface tension of gas bubbles in the gastrointestinal tract, allowing them to merge into larger bubbles that can be more easily expelled through belching or flatulence, thereby reducing abdominal pressure.

The appropriate dose of Ilio-Funkton is determined by the prescribing healthcare professional based on the patient’s age, condition and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety data for Simeticone in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Ilio-Funkton with their healthcare provider before starting treatment.

To order Ilio-Funkton, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ilio-Funkton’s active ingredient Simeticone is a non‑systemic surfactant, unlike some antispasmodic or probiotic agents. It works locally in the gut without being absorbed, offering a rapid, targeted approach to gas relief with a low risk of systemic side effects.

Ilio-Funkton should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Ilio-Funkton is taken orally. The tablet or liquid is swallowed with water as directed by the prescriber, typically after meals or as needed for symptom relief, following the dosage instructions on the label.

Serious but rare risks include allergic reactions such as rash, itching, swelling, angioedema or anaphylaxis. If any signs of a severe allergic response occur, discontinue use immediately and seek medical attention.

Ilio-Funkton should be avoided in individuals with known hypersensitivity to Simeticone or any excipients in the formulation, and in patients with gastrointestinal obstruction or severe motility disorders unless advised otherwise by a healthcare professional.